Tag: RIVER study
Long-term data support durability of River stent in IIH treatment
Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company, has announced four-to-five-year results from the RIVER study, which is described as the first multicentre evaluation...
Serenity gains “landmark” US FDA humanitarian device exemption for novel cerebral...
Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company, has today announced a “landmark” US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for its novel...
Safety of venous sinus stenting in IIH patients established via one-year...
A prospective study has established the safety of venous sinus stenting (VSS) using a novel device in idiopathic intracranial hypertension (IIH) patients who have...
